The Activation Status of the TGF-β Transducer Smad2 Is Associated with a Reduced Survival in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Aug 2019
Historique:
received: 09 07 2019
revised: 31 07 2019
accepted: 01 08 2019
entrez: 8 8 2019
pubmed: 8 8 2019
medline: 8 1 2020
Statut: epublish

Résumé

Aberrant function of Smad2, a crucial member of transforming growth factor beta (TGF-β) signaling, is associated with the development of malignancies, particularly in the gastrointestinal district. However, little is known about its possible prognostic role in such tumor types. With the first meta-analysis on this topic, we demonstrated that the lack of the activated form of Smad2 (phosphor-Smad2 or pSmad2), which was meant to be the C-terminally phosphorylated form, showed a statistically significant association with an increased risk of all-cause mortality in patients with gastrointestinal cancers (RR, 1.58; 95% CI, 1.05-2.37,

Identifiants

pubmed: 31387321
pii: ijms20153831
doi: 10.3390/ijms20153831
pmc: PMC6695973
pii:
doi:

Substances chimiques

Biomarkers 0
SMAD2 protein, human 0
Smad2 Protein 0
Transforming Growth Factor beta 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cell. 2000 Jan 21;100(2):189-92
pubmed: 10660041
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Int J Oncol. 2000 Oct;17(4):723-8
pubmed: 10995883
Curr Opin Oncol. 2001 Jan;13(1):70-7
pubmed: 11148690
Mol Cell Biol. 2001 May;21(10):3302-13
pubmed: 11313456
Clin Cancer Res. 2001 Jun;7(6):1618-26
pubmed: 11410498
Immunol Lett. 2002 Jun 3;82(1-2):85-91
pubmed: 12008039
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
J Surg Oncol. 2006 Jul 1;94(1):51-6
pubmed: 16788944
Biochim Biophys Acta. 2007 Jan;1775(1):21-62
pubmed: 16904831
Cancer Cell. 2007 Feb;11(2):147-60
pubmed: 17292826
Cell Res. 2009 Feb;19(2):156-72
pubmed: 19153598
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Future Oncol. 2009 Oct;5(8):1145-68
pubmed: 19852727
Biochem Biophys Res Commun. 2010 Oct 22;401(3):376-81
pubmed: 20854793
BMC Cancer. 2010 Nov 26;10:652
pubmed: 21110833
Nature. 2011 Feb 10;470(7333):269-73
pubmed: 21289624
Biochem Biophys Res Commun. 2011 Apr 1;407(1):181-4
pubmed: 21371426
Oncol Rep. 2011 Jun;25(6):1581-7
pubmed: 21479366
Carcinogenesis. 2011 Nov;32(11):1578-88
pubmed: 21798854
Gastroenterology. 2011 Oct;141(4):1167-78
pubmed: 21839702
Tumour Biol. 2012 Aug;33(4):1005-14
pubmed: 22278155
Cancer Res. 2013 Jan 15;73(2):725-35
pubmed: 23139211
Eur J Cancer Prev. 2013 Sep;22(5):420-4
pubmed: 23426176
Cytokine Growth Factor Rev. 2013 Aug;24(4):385-99
pubmed: 23871609
Nat Rev Cancer. 2013 Nov;13(11):788-99
pubmed: 24132110
Cancer. 2014 Aug 15;120(16):2412-23
pubmed: 24798237
World J Surg Oncol. 2014 Nov 05;12:328
pubmed: 25373709
Neoplasma. 2015;62(4):646-57
pubmed: 25997968
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45
pubmed: 26343745
Placenta. 2015 Nov;36(11):1318-24
pubmed: 26459371
J Surg Oncol. 2015 Dec;112(8):828-33
pubmed: 26493240
Eur J Gastroenterol Hepatol. 2016 Feb;28(2):205-9
pubmed: 26566063
Ann Oncol. 2016 May;27(5):955-6
pubmed: 26802150
Cancer Lett. 2016 Sep 1;379(2):166-72
pubmed: 27039259
J Clin Pathol. 2016 Jul 7;:null
pubmed: 27387986
J Gastrointest Surg. 2016 Oct;20(10):1692-8
pubmed: 27412320
Surg Pathol Clin. 2016 Dec;9(4):547-560
pubmed: 27926359
Virchows Arch. 2017 Jun;470(6):665-678
pubmed: 28432432
Hum Pathol. 2017 Jul;65:62-70
pubmed: 28438617
Int J Mol Sci. 2017 May 06;18(5):null
pubmed: 28481241
J Pathol. 2017 Oct;243(2):148-154
pubmed: 28722124
Crit Rev Oncog. 2017;22(3-4):275-282
pubmed: 29604904
Cancers (Basel). 2018 May 25;10(6):null
pubmed: 29799477
Cancers (Basel). 2018 Jun 05;10(6):null
pubmed: 29874844
Front Med. 2018 Aug;12(4):361-373
pubmed: 30043221
World J Gastrointest Oncol. 2018 Oct 15;10(10):317-327
pubmed: 30364837
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Cancer Sci. 2019 Feb;110(2):481-488
pubmed: 30589983
Oncogene. 2019 Apr;38(17):3232-3247
pubmed: 30626937
Cancers (Basel). 2019 Jan 19;11(1):null
pubmed: 30669452
PLoS One. 2019 Feb 7;14(2):e0212142
pubmed: 30730996
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Nature. 1997 Dec 4;390(6659):465-71
pubmed: 9393997
Cell. 1998 Dec 11;95(6):737-40
pubmed: 9865691

Auteurs

Ilaria Girolami (I)

Department of Diagnostics and Public Health, Section of Pathology, University of Verona, 37134 Verona, Italy.

Nicola Veronese (N)

National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, 70013 Bari, Italy.

Lee Smith (L)

The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge CB1 1PT, UK.

Maria G Caruso (MG)

National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, 70013 Bari, Italy.

Rosa Reddavide (R)

National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, 70013 Bari, Italy.

Gioacchino Leandro (G)

National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, 70013 Bari, Italy.

Jacopo Demurtas (J)

Primary Care Department, Azienda USL Toscana Sud Est, 58100 Grosseto, Italy.

Alessia Nottegar (A)

Department of Diagnostics, Section of Pathology, San Bortolo Hospital, 36100 Vicenza, Italy. alessia.nottegar@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH